Lung tumors treated with percutaneous radiofrequency ablation: Computed tomography imaging follow-up

CardioVascular and Interventional Radiology

Volumn 34, Issue 5, 2011, Pages 989-997

  Palussière, Jean ^a   Marcet, Benjamin ^a   Descat, Edouard ^a   Deschamps, Frédéric ^c   Rao, Pramod ^c   Ravaud, Alain ^b   Brouste, Véronique ^a   De Baère, Thierry ^c  

^a INSTITUT BERGONIÉ   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATELECTASIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INTERVENTIONAL RADIOLOGY; LUNG CAVITATION; LUNG FIBROSIS; LUNG NODULE; LUNG PARENCHYMA; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

CATHETER ABLATION; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80555145994     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-0048-z     Document Type: Article

References (36)

1. Abbas G, Schuchert MJ, Pennathur A et al (2007) Ablative treatments for lung tumors: radiofrequency ablation, stereotactic radiosurgery, and microwave ablation. Thorac Surg Clin 17:261-271 (Pubitemid 46876660)
2. Dupuy DE, Mayo-Smith WW, Abbott GF et al (2002) Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 22(Spec No.):S259-S269 (Pubitemid 41569711)
3. Rose SC, Thistlethwaite PA, Sewell PE et al (2006) Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 17:927-951 (Pubitemid 44321404)
4. de Baère T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean followup of more than 1 year. AJR Am J Roentgenol 175:1619-1625
5. Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepato-cellular carcinoma in cirrhosis: randomized comparison ofradio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235-240 (Pubitemid 36736097)
6. Mc Grane S, Mc Sweeney SE, Maher MM (2008) Which patients will benefit from percutaneous radiofrequency ablation of colo-rectal liver metastases? Critically appraised topic. Abdom Imaging 33:48-53
7. Suppiah A, White TJ, Roy-Choudhury SH et al (2007) Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomes. Dig Surg 24:358-360 (Pubitemid 47519245)
8. Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities. Part II. J Vasc In-terv Radiol 12:1135-1148 (Pubitemid 32983350)
9. Zagoria RJ, Traver MA, Werle DM et al (2007) Oncologic effi-cacy of computed tomography (CT)-guided percutaneous radio-frequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189:429-436 (Pubitemid 47195930)
10. Park S, Cadeddu JA (2007) Outcomes ofradiofrequency ablation for kidney cancer. Cancer Control 14:205-210 (Pubitemid 47057789)
11. Link TM, de Mayo R, O'Donnell RJ (2007) Radiofrequency ablation: an alternative for definitive treatment of solitary bone metastases. Eur Radiol 17:3012-3013 (Pubitemid 47604000)
12. Suh R, Reckamp K, Zeidler M et al (2005) Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology (Williston Park) 19(11 Suppl 4):12-21
13. Simon CJ, Dupuy DE, Di Petrillo TA et al (2007) Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 243:268-275 (Pubitemid 46579719)
14. Yan TD, King J, Sjarif A et al (2006) Percutaneous radiofre-quency ablation of pulmonary metastases from colorectal carci-noma: prognostic determinants for survival. Ann Surg Oncol 13:1529-1537 (Pubitemid 44749666)
15. Yan TD, King J, Sjarif A et al (2007) Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol 14:1718-1726 (Pubitemid 46790987)
16. de Baère T, Palussière J, Auperin A et al (2006) Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240:587-596 (Pubitemid 44098659)
17. Therasse P (2002) Evaluation of response: new and standard criteria. Ann Oncol 13(Suppl 4):127-129 (Pubitemid 35363763)
18. Shuster JJ (1991) Median follow-up in clinical trials. J Clin Oncol 9:191-192
19. Ahmed M, Liu Z, Afzal KS et al (2004) Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 230:761-767 (Pubitemid 38252874)
20. Goldberg SN, Gazelle GS, Compton CC et al (1995) Radiofre-quency tissue ablation in the rabbit lung: efficacy and compli-cations. Acad Radiol 2:776-784
21. Yamamoto A, Nakamura K, Matsuoka T et al (2005) Radiofre-quency ablation in a porcine lung model: correlation between computed tomography (CT) and histopathologic findings. AJR Am J Roentgenol 185:1299-1306
22. Suh RD, Wallace AB, Sheehan RE et al (2003) Unresectable pulmonary malignancies: computed tomography (CT)-guided percutaneous radiofrequency ablation: preliminary results. Radiology 229:821-829 (Pubitemid 37467589)
23. Steinke K, Glenn D, King J et al (2004) Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pul-monary metastases: 1-year follow-up. Ann Surg Oncol 11:207-212 (Pubitemid 40486798)
24. Bojarski JD, Dupuy DE, Mayo-Smith WW (2005) computed tomography (CT) imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: Results in 32 tumors. AJR Am J Roentgenol 185:466-471
25. Lee JM, Jin GY, Goldberg SN et al (2004) Percutaneous radio-frequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 230:125-134 (Pubitemid 37549793)
26. Anderson EM, Lees WR, Gillams AR (2009) Early indicators of treatment success after percutaneous radiofrequency of pulmon-ary tumors. Cardiovasc Intervent Radiol 32:478-483
27. Brace CL, Diaz TA, Hinshaw JL et al (2010) Tissue contraction caused by radiofrequency and microwave ablation: a laboratory study in liver and lung. J Vasc Interv Radiol 21:1280-1286
28. Hakimé A, Peddi H, Hines-Peralta AU et al (2007) computed tomography (CT) perfusion for determination of pharmacologi-cally mediated blood flow changes in an animal tumor model. Radiology 243:712-719 (Pubitemid 46799424)
29. Schaefer JF, Vollmar J, Schick F et al (2004) Solitary pulmonary nodules: Dynamic contrast-enhanced MR imaging-perfusion differences in malignant and benign lesions. Radiology 232:544-553 (Pubitemid 38971298)
30. Van Sonnenberg E, Shankar S, Morrison PR et al (2005) Radio-frequency ablation of thoracic lesions. Part 2. Initial clinical experience: technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 184:381-390 (Pubitemid 46657237)
31. Okuma T, Matsuoka T, Yamamoto A et al (2009) Assessment of early treatment response after computed tomography (CT)-guided radiofrequency ablation of unresectable lung tumours by diffu-sion-weighted MRI: a pilot study. Br J Radiol 82:989-994
32. Okuma T, Matsuoka T, Okamura T et al (2006) F-FDG small-animal PET for monitoring the therapeutic effect of computed tomography (CT)-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47:1351-1358 (Pubitemid 47544891)
33. Okuma T, Okamura T, Matsuoka T et al (2006) Fluorine-18- fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after computed tomography (CT)-guided radiofrequency abla-tion: preliminary results. Ann Nucl Med 20:115-121
34. Avril N (2006) F-FDG PET after radiofrequency ablation: Is timing everything? J Nucl Med 47:1235-1237 (Pubitemid 47544872)
35. Hataji O, Yamakado K, Nakatsuka A et al (2005) Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation. Intern Med 44:865-869 (Pubitemid 41263836)
36. Okuma T, Matsuoka T, Yamamoto A et al (2007) Factors con-tributing to cavitation after computed tomography (CT)-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol 18:399-404 (Pubitemid 46616713)